BioCatalystWatch
OCGNWorkspace / OCGN / OverviewCompany library
Price
Market cap
Next catalystExpected Q1 2027OCU400 — Phase 3 liMeliGhT · Phase 3 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

OCU400

PreINDP1P2P3FilingApproved
Upcoming / outlook

OCU410ST

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

OCU410

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

OCU400

PreINDP1P2P3FilingApproved
Upcoming / outlook

OCU410

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

OCU410ST

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

OCU410ST

PreINDP1P2P3FilingApproved

Integrin receptors × Transferrin receptors

Integrin receptors × Transferrin receptors

OCU400

PreINDP1P2P3FilingApproved
OCU410

PreINDP1P2P3FilingApproved

Partner / License out

OCU400

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

OCGN SEC archive